Covid: scientists may have found ‘trigger’ for very rare blood clot complications with AstraZeneca jab

AstraZeneca said it would use these findings as “part of our efforts to remove this extremely rare side effect”

This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement.

Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

Scientists may have found the “trigger” behind the incredibly rare blood clot complications stemming from the Oxford/AstraZeneca vaccine.

An international team of researchers from Cardiff and the US have found that a protein in the blood is attracted to a component in the vaccine.

Hide Ad
Hide Ad

They believe this may spark a chain reaction in the immune system which can culminate in the development of blood clots – a condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).

What was said about AZ jab’s links to rare blood clots

Professor Alan Parker, from Cardiff University’s School of Medicine, said: “VITT only happens in extremely rare cases because a chain of complex events needs to take place to trigger this ultra-rare side effect.

“Our data confirms PF4 can bind to adenoviruses, an important step in unravelling the mechanism underlying VITT. Establishing a mechanism could help to prevent and treat this disorder.

“We hope our findings can be used to better understand the rare side effects of these new vaccines – and potentially to design new and improved vaccines to turn the tide on this global pandemic,” he added.

What AstraZeneca said about the findings

Hide Ad
Hide Ad

Scientists from AstraZeneca also took part in the research, which was published in the journal Science Advances.

A spokeswoman for the company told the BBC: “Although the research is not definitive, it offers interesting insights and AstraZeneca is exploring ways to leverage these findings as part of our efforts to remove this extremely rare side effect.”

A message from the editor:

Thank you for reading. NationalWorld is a new national news brand, produced by a team of journalists, editors, video producers and designers who live and work across the UK. Find out more about who’s who in the team, and our editorial values. We want to start a community among our readers, so please follow us on Facebook, Twitter and Instagram, and keep the conversation going.

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.